PsyBio Therapeutics Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PsyBio Therapeutics Corp. generated cash of -$3,437,030, which is more than the previous year. Cash used in financing activities reached the amount of -$54,977 last year. Net change in cash is therefore $32,866.
Cash Flow
| 2018 | -39.71K | 0 | -5.54K |
|---|---|---|---|
| 2020 | -24.13K | 0 | 0 |
| 2021 | -6.94M | -3.56M | 10.36M |
| 2022 | -3.43M | 3.52M | -54.97K |
PSYB.V Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2019 | 2017 | |
|---|---|---|---|---|
Cash at beginning of period | 124.39K | 269.7K | 193.54K | 254.15K |
Operating activities | ||||
Net income | -4.88M | -11.01M | -16.15K | -39.85K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 152.08K | 0 | 0 | 0 |
Stock-based compensation expense | 508.70K | 2.12M | 0 | 0 |
| Deferred income tax benefit | 508.70K | 2.12M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 13.81K | 0 | 0 |
Inventories | 0 | 14.81K | 0 | 0 |
Accounts payable | 843.66K | 489.28K | 0 | 0 |
Cash generated by operating activities | -3.43M | -6.94M | -24.13K | -39.71K |
Investing activities | ||||
Purchases Of Investments | -336.16K | -8.16M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 175.76K | 0 | 0 |
Cash generated by investing activities | 3.52M | -3.56M | 0 | 0 |
Financing activities | ||||
Common Stock Issued | 156.41K | 11.27M | 0 | -5.54K |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | -88.10K | 0 | 0 | 0 |
Repayments of term debt | -123.28K | 0 | 0 | 0 |
Cash used in financing activities | -54.97K | 10.36M | 0 | -5.54K |
Net Change In Cash | 32.86K | -145.30K | -31.98K | -48.06K |
Cash at end of period | 157.25K | 124.39K | 161.56K | 206.08K |